SCHEMBL9367016

SCHEMBL9367016

Clc1ccccc1C(Cc1ccccc1)N1CCCCC1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.64
CYP2D6 P10635 2/20 0.64
CYP2C19 P33261 2/20 0.64
CYP3A4 P08684 1/20 0.64
TSHR P16473 1/20 0.64
HRH3 Q9Y5N1 2/20 0.53
DPP4 P27487 1/20 0.50
SLC6A2 P23975 7/20 0.45
SLC6A4 P31645 7/20 0.45
MC4R P32245 1/20 0.45
RAB9A P51151 2/20 0.41
TACR1 P25103 1/20 0.41
OPRL1 P41146 2/20 0.41
SLC6A3 Q01959 3/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
PARP1 P09874 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8278787 0.80 DPP4 (0.73) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL3470666 0.80 DPP4 (0.73) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL9366048 0.79 CYP2C19 (0.60) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL9365969 0.79 CYP2D6 (0.60) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL19634040 0.79 MC4R (0.55) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL3715253 0.78 CYP1A2 (1.00) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL9366741 0.76 CYP1A2 (0.96) CYP1A2CYP2D6CYP2C19CYP3A4TSHR
SCHEMBL6201655 0.76 CYP1A2 (0.68) CYP1A2CYP2C19TSHRDPP4SLC6A2
SCHEMBL14451970 0.75 DPP4 (0.50) CYP2D6DPP4SLC6A2SLC6A4MC4R
SCHEMBL9366991 0.75 CYP1A2 (0.79) CYP1A2CYP2D6CYP2C19CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP claimed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP claimed
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP disclosed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP disclosed